文献速递产科麻醉区域麻醉与超声

剖宫产腰麻高比重布比卡因剂量与产妇低血压的关系:8226例回顾性数据库研究

Association Between Hyperbaric Bupivacaine Dose and Maternal Hypotension: Retrospective Database Study of 8226 Women Undergoing Cesarean Delivery Under Spinal Anesthesia.
PubMed 文献 · Anesth Analg · 2021-01-01

该回顾性研究纳入2012至2018年单中心两个院区8226例腰麻或腰硬联合麻醉下剖宫产产妇,分析高比重布比卡因剂量与腰麻后低血压的关系。

要点

  • 高比重布比卡因剂量≥10 mg与剖宫产腰麻后低血压发生率升高独立相关。
  • 即使使用低剂量(<10 mg),腰麻后低血压仍可发生,需常规监测与防治。
  • 调整混杂因素后,高比重布比卡因剂量≥10 mg与脐带血pH<7.2无显著关联。

核心结论

  • 高比重布比卡因剂量≥10 mg与剖宫产腰麻后低血压发生率显著升高独立相关,但低血压可在所有剂量下发生。

研究设计与样本

  • 回顾性数据库研究,纳入2012至2018年单中心两个院区8226例腰麻或腰硬联合麻醉下剖宫产产妇。

主要发现

  • 高比重布比卡因剂量<9 mg者2395例(29.1%),9-9.5 mg者1031例(12.5%),10 mg者4155例(50.5%),>10 mg者645例(7.8%)。

临床怎么用

  • 剖宫产腰麻时选择高比重布比卡因剂量应权衡麻醉效果与低血压风险,低剂量(<10 mg)可能降低低血压发生率。
  • 无论选择何种剂量,均应加强血压监测并做好低血压防治准备。

局限性

  • 回顾性研究设计,可能存在未测量的混杂因素。
  • 脐带血pH数据仅覆盖32.6%的病例,相关分析样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose (≤8 mg) hyperbaric bupivacaine for spinal anesthesia during cesarean delivery results in reduced efficacy, yet as a secondary outcome was associated with reduced frequency of spinal-induced hypotension. Our primary aim was to investigate the relationship between hyperbaric bupivacaine dose and the occurrence of spinal-induced hypotension for cesarean delivery. METHODS: Retrospective study of cesarean delivery under spinal or combined spinal anesthesia with hyperbaric bupivacaine in 1 academic institution (2 centers-tertiary and district) from 2012 to 2018. Data were retrieved from the anesthesia information management systems (Metavision, iMDsoft, Tel Aviv, Israel) and the hospital information system, including potential confounding factors, maternal age and weight, hypertensive disease of pregnancy, single/multiple gestation, gestational age, vasopressor administration, planned/urgent surgery, position during anesthesia placement (sitting/lateral), and anesthesiologist seniority. Spinal-induced hypotension was defined as systolic blood pressure that either dropped >20% from baseline or <100 mm Hg. The primary outcome of interest was the incidence of spinal-induced hypotension according to hyperbaric bupivacaine dose. Logistic regression was used to characterize the association between the dose of hyberbaric bupivacaine and spinal-induced hypotension after adjusting for confounding factors. RESULTS: A total of 8226 women were identified. The hyperbaric bupivacaine dose administered was <9 mg for 2395 (29.1%), 9-9.5 mg for 1031 (12.5%), 10 mg for 4155 (50.5%), and >10 mg for 645 (7.8%). We used a cutoff (<10 vs ≥10 mg) to assess for the primary outcome, using multivariable logistic regression. The incidence of at least 1 spinal-induced hypotension episode was higher in patients who received ≥10 mg hyperbaric bupivacaine, 75.8% vs 62.9% for doses below 10 mg, P < .0001; however, even women with lower doses had hypotension. Hyperbaric bupivacaine dose <10 mg was associated with a lower incidence of spinal hypotension, adjusted odds ratio (OR) of 0.774, 95% confidence interval (CI), 0.669-0.897, and P = .0006, adjusted for confounding factors.Umbilical cord pH was available for 2684 (32.6%) cases. There were significantly more neonates with pH < 7.2, among women who received hyperbaric bupivacaine ≥10 mg (10.1%) versus women who received <10 mg (6.8%), P = .0032; however, in the adjusted model, hyperbaric bupivacaine dose ≥10 mg was not associated with pH < 7.2 and an OR of 0.955 (95% CI, 0.631-1.446, P = .829). CONCLUSIONS: Our major finding was that hypotension occurred at all doses of hyperbaric bupivacaine, yet occurrence of spinal hypotension was significantly associated with doses ≥10 mg after adjustment for potential confounders.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Weiniger CF, Heesen M, Knigin D, et al. Association Between Hyperbaric Bupivacaine Dose and Maternal Hypotension: Retrospective Database Study of 8226 Women Undergoing Cesarean Delivery Under Spinal Anesthesia. Anesth Analg. 2021. PMID: 33780385. doi:10.1213/ANE.0000000000005518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。